Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zymeworks Inc (NY: ZYME ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zymeworks Inc < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > 2 Biotech Stocks That Could Make You Richer July 14, 2023 These biotech companies are seeing a spike in revenue growth. Via The Motley Fool Why These 7 Stocks Are the Best Ways to Play Biotech Right Now July 11, 2023 With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look. Via InvestorPlace Zymeworks Announces Participation in Upcoming Investor Conference July 03, 2023 From Zymeworks Inc. Via GlobeNewswire Zymeworks Appoints New Director June 29, 2023 From Zymeworks Inc. Via GlobeNewswire 7 Analysts Have This to Say About Zymeworks June 06, 2023 Via Benzinga 5 Value Stocks In The Healthcare Sector May 29, 2023 Via Benzinga What 6 Analyst Ratings Have To Say About Zymeworks May 18, 2023 Via Benzinga Overview Of Value Stocks In The Healthcare Sector April 10, 2023 Via Benzinga Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes June 26, 2023 From Zymeworks Inc. Via GlobeNewswire Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying June 22, 2023 Although US stocks closed lower on Wednesday, there were a few notable insider trades. Via Benzinga The 3 Most Undervalued Growth Stocks for Your June Buy List June 11, 2023 Sometimes you can get the best of both worlds in the equities sector, which should draw interest for these undervalued growth stocks. Via InvestorPlace 3 Cheap Growth Stocks That Are Too Good to Pass Up June 05, 2023 These top bargain growth stocks are all priced under $10 a share and offer real upside potential for investors. Via InvestorPlace Zymeworks Announces Participation in Upcoming Investor Conferences June 01, 2023 From Zymeworks Inc. Via GlobeNewswire What 7 Analyst Ratings Have To Say About Zymeworks March 31, 2023 Via Benzinga Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact March 20, 2023 Via Benzinga Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer May 18, 2023 From Zymeworks Inc. Via GlobeNewswire Top 5 Health Care Stocks That May Collapse In Q2 May 10, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Zymeworks Provides Corporate Update and Reports First Quarter 2023 Financial Results May 08, 2023 From Zymeworks Inc. Via GlobeNewswire Earnings Scheduled For May 8, 2023 May 08, 2023 Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million. Via Benzinga Analyst Ratings for Zymeworks March 08, 2023 Via Benzinga Zymeworks Announces Participation in Upcoming Investor Conferences May 01, 2023 From Zymeworks Inc. Via GlobeNewswire Zymeworks Presents New Data from Multiple Preclinical and Clinical Development Programs at the 2023 American Association for Cancer Research Annual Meeting April 18, 2023 From Zymeworks Inc. Via GlobeNewswire The 7 Most Undervalued Stocks You Need to Know About April 18, 2023 Given the risks targeting highly popular trades right now, the most undervalued stocks to buy may offer greater mileage. Via InvestorPlace Zymeworks To Host First Quarter 2023 Results Conference Call April 17, 2023 From Zymeworks Inc. Via Business Wire Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors April 10, 2023 From Zymeworks Inc. Via Business Wire Zymeworks Announces Participation in Upcoming Investor Conferences April 03, 2023 From Zymeworks Inc. Via Business Wire Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting March 14, 2023 From Zymeworks Inc. Via Business Wire Zymeworks Offers Hope for More than Just Long-Term Investors March 09, 2023 Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher Via MarketBeat Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket March 08, 2023 Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1... Via Benzinga Zymeworks Reports Fourth Quarter and Full Year 2022 Financial Results March 07, 2023 From Zymeworks Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.